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Abstract
Erythropoietic protoporphyria (EPP) is an extremely rare disease which is often
unrecognized as diagnosis. In the recent article Lui et al describe a patient with a
new diagnosis of EPP with severe liver injury. Approximately 5%-20% of patients
with EPP develop liver manifestations. The most severe complication of EPP is an
hepatic crisis, which is a medical emergency requiring urgent treatment.
Intensive treatment should consist of (exchange) transfusions and preferably in a
center that performs liver transplantations.
Key words: Erythropoietic protoporphyria; Liver disease; Blood transfusion;
Protoporphyrin IX; Treatment
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Core tip: Erythropoietic protoporphyria (EPP) can be complicated by severe liver injury.
The major highlight of this letter is to stress that an EPP hepatic crisis has to be
recognized as it can be fatal, and the best therapeutic options are (exchange) transfusions
and preferably in a center that performs liver transplantations.
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TO THE EDITOR
With  great  interest  we  read  the  case  report  on  the  diagnosis  of  erythropoietic
protoporphyria (EPP) with severe liver injury by Liu et al[1] in the February 2019 issue
of World Journal of Gastroenterology. They report a case presenting with weight loss,
jaundice, and hepatitis. After extensive investigation the diagnosis of EPP was made
and the liver disease was explained as related to EPP. We greatly appreciate the
dedication of the authors to improve awareness of EPP and EPP related liver injury in
order to aid early recognition.
In addition to their paper, we like to propose treatment options for severely ill
patients. Approximately 5%-20% of patients with EPP develop liver manifestations[2].
Hepatic manifestations of the disease are diverse, ranging from mildly disturbed liver
enzymes, choledocholithiasis at early age to fatal hepatic failure. The case of Liu et al
reports elevated transaminases, hyperbilirubinemia, enlargement of the liver and
ascites on magnetic resonance imaging (MRI) suggesting severe liver disease. The
most severe complication of EPP, which can rapidly result in fatal hepatic failure, is
cholestatic liver failure, which we, by analogy with the hepatic crises of sickle cell
disease,  designate as  an EPP hepatic  crisis,  to  accentuate that  this  condition is  a
medical emergency requiring urgent treatment. These EPP crises present with severe
abdominal  pain,  jaundice,  and  biochemically  severe  cholestatic  hepatitis,
accompanied by a significant increase in erythrocyte and plasma protoporphyrin IX
over preexisting levels. During a hepatic crisis, which is often provoked when the
liver is damaged by another cause such as alcohol consumption or viral hepatitis, the
biliary excretion of protoporphyrin is reduced, leading to a rise of protoporphyrin
levels which may further damage the canaliculi and biliary tract. This results in a
vicious circle causing further liver damage and rapidly leads to acute liver failure if
left untreated. In case of a hepatic crisis the suggested treatment of Liu et al, consisting
of avoiding light,  drinking glucose water,  and a carrot diet including β carotene,
resulted  in  recovery  of  their  patient.  We suggest  a  more  intensive  treatment  in
severely ill patients to prevent possible fatal outcome. The cornerstone of this therapy
is to quickly lower protoporphyrin levels in order to provide an opportunity for the
liver  to  recover.  This  can be achieved with exchange transfusions[3].  In  addition,
suppression of hematopoiesis and endogenous protoporphyrin production via blood
transfusions to supraphysiological hemoglobin levels should be considered[4]. If this
treatment fails, liver transplantation is the only treatment option left[5]. Because of the
severity of EPP-related liver crises, prevention of liver damage should be attempted in
all EPP patients, by advising against and restricting alcohol consumption, avoiding
potentially hepatotoxic drugs and vaccinating against hepatitis A and B virus[6].
To  conclude,  a  severe  EPP  hepatic  crisis  can  be  fatal  and  should  be  treated
intensively via (exchange) transfusions and preferably in a center that performs liver
transplantations.
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